| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 22.142 | 39.627 | 30.547 | 39.714 | 152.052 | 207.536 | 203.772 |
| Total Income - EUR | - | - | - | 22.143 | 39.627 | 30.547 | 39.714 | 152.052 | 207.581 | 203.772 |
| Total Expenses - EUR | - | - | - | 8.772 | 12.800 | 15.702 | 16.437 | 70.732 | 104.358 | 116.250 |
| Gross Profit/Loss - EUR | - | - | - | 13.371 | 26.827 | 14.845 | 23.277 | 81.320 | 103.222 | 87.522 |
| Net Profit/Loss - EUR | - | - | - | 12.707 | 25.639 | 13.990 | 22.393 | 80.328 | 101.452 | 82.326 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Anatol Saf Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 540 | 2.692 | 2.275 | 35.769 | 79.756 | 126.118 | 103.777 |
| Current Assets | - | - | - | 44.581 | 64.571 | 79.365 | 79.925 | 76.879 | 59.890 | 132.647 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 109 | 29.596 |
| Receivables | - | - | - | 35.284 | 38.147 | 35.831 | 36.971 | 33.018 | 29.863 | 1.495 |
| Cash | - | - | - | 9.297 | 26.423 | 43.534 | 42.955 | 43.861 | 29.918 | 101.556 |
| Shareholders Funds | - | - | - | 12.750 | 38.142 | 51.408 | 72.661 | 153.215 | 150.586 | 199.616 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 32.371 | 29.121 | 30.232 | 43.033 | 3.420 | 35.423 | 36.809 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Anatol Saf Med S.r.l.